CRISPR Therapeutics AG (CRSP)
55.69
-1.07
(-1.89%)
USD |
NASDAQ |
Apr 16, 16:00
55.64
-0.05
(-0.09%)
After-Hours: 20:00
CRISPR Therapeutics EPS Diluted (Quarterly) : -1.371 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -130.61M |
| Revenue (Quarterly) | 0.864M |
| Total Expenses (Quarterly) | 131.48M |
| Enterprise Value | 3.671B |
| Gross Profit Margin (Quarterly) | -6.77K% |
| Profit Margin (Quarterly) | -15.12K% |
| Earnings Yield | -11.70% |
| Normalized Earnings Yield | -10.46 |